Teva, Mylan, Other Generic Makers Hit With Price-Fixing Suit
UnitedHealthcare on Friday accused Teva, Mylan and more than a dozen other generic-drug makers of an egregious price-fixing scheme, claiming executives divvied up market share over fine Scotch and inflated the prices...To view the full article, register now.
Already a subscriber? Click here to view full article